Per varie impostazioni per cheratocono e cheratite infettiva.
Profilo regolato per lo spessoreIl profilo del raggio offre maggiore energia nella periferia della cornea.
Tecnologia della batteria superioreProgettata per durare migliaia di trattamenti.
Accessibile alle sedie a rotelleTrattare comodamente le persone in sedia a rotelle
Per CXL moderno: si adatta a lampade a fessura con design Haag Streit e Zeiss.
Supporto per tavoloFor classic CXL: table mount accessory available.
Protocolli integratiScegli fra diversi protocolli clinici predefiniti.
Intervallo di intensitÃDelivers 3, 9, 15, 18 and 30 mW/cm².
Il dispositivo C-eye ha il marchio CE per le seguenti indicazioni: cheratocono, ectasia dopo LASIK/PRK, degenerazione marginale pellucida, cheratite infettiva, fusione corneale sterile, cheropatia bollosa.
Il dispositivo C-eye di EMAGine porta la tecnologia del cross-linking alla lampada a fessura. Semplice, efficace e sicuro, dal principiante all’utente esperto.
Esegui CXL alla lampada a fessura. O usa il dispositivo C-eye come ogni altro dispositivo CXL: su un supporto da tavolo, o in sala operatoria.
Lavori in vari posti? Porta con te ovunque il dispositivo C-eye. Caricalo tramite USB-C, col tuo caricatore per smartphone, o tramite il tuo laptop.
Riduce tempi e costi relativi all'esecuzione di CXL
Remember that every cross-linking procedure not only improves biomechanics, it also ?disinfects? the cornea by directly killing all micro-organisms and by inhibiting cellular replication. This is why a cornea at the end of every CXL and PACK-CXL procedure is ?sterile?. And by the way: office-based cataract surgery e office-based intravitreal injections have been performed in many thousands of cases without increased infection risk.
Irradiation time is not too long. Current modern protocols are integrated in the C-eye device and treat in as little as 10 minutes (CXL) and 4 minutes (PACK-CXL). See the published approach qui.
We need 3 elements for successful cross-linking: UV light, oxygen and riboflavin. Both UV light and oxygen do not ?care? whether the patient is laying down or sitting. As for riboflavin, published research shows that riboflavin concentration is stable in the upright position for up to 60 minutes - much longer than we need for a CXL treatment.
Offer the patient the comfortable surgeon?s chair with the armrest and take the extra time to ensure that the patient is well-adjusted. Then, the patient is very comfortable.
Fixation is no issue. Offer the patient the fixation target that most slit lamps offer (for retinal examination) and the patient will keep a very steady fixation, as you can see qui.
Find more answers in our FAQ section.
La tecnologia CXL più versatile e completa disponibile.
The C-eye device fits to a number of Haag-Streit and Zeiss type slit lamps. Find here the complete list of compatible slit lamps
One Riboflavin for
Keratoconus and Keratitis
EMAGine’s Medical Director, Prof. Farhad Hafezi, and its CEO, Nikki Hafezi, presented remotely at the CXL Experts’ Summer Meeting 2023,
The article by Lu et al. reports an in vitro study, conducted to determine whether high-fluence PACK-CXL can be accelerated while still maintaining its antibacterial efficacy. The study found that high-fluence PACK-CXL did indeed decrease the bacterial concentration of several clinically significant bacterial strains, including S. aureus, P. aeruginosa, and S. epidermidis. These strains are commonly implicated in bacterial keratitis and contact lens-associated keratitis. Furthermore, the authors found that higher total fluence PACK-CXL protocols led to a corresponding increase in bacterial killing ratio (BKR).
Prof. Farhad Hafezi, MD, PhD, FARVO is the Medical Director at The ELZA Institute, was recently interviewed by Ocular Surgery News
The advantages of performing corneal cross-linking (CXL) at the slit lamp are well established. It brings CXL out of the
It has been quite the debate. Should surgeons drop riboflavin onto the cornea during the UV irradiation part of a
Photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL) has progressed a great deal since it was first developed (1) as a treatment
EMAGine’s Chief Scientific Officer, Professor Farhad Hafezi of the ELZA Institute in Zurich, Switzerland, has prepared a presentation that provides a comprehensive overview of how oxygen concentration is at the center of all these decisions.
Gennaio 21, 2022
NUHS 36th Anniversary Conference
Location: Singapore
Language: English
Gennaio 15, 2022
Muscat International Ophthalmology Conference (MIOC)
Location: Muscat, Oman
Language: English
Dicembre 4, 2021
Kölner Adventssymposium 2021
Location: Köln, Germany
Language: German
Novembre 25, 2021
Middle East Africa Council of Ophthalmology
Location: Dubai, UAE
Language: English
Novembre 18, 2021
14th World Down Syndrome Congress
Location: Dubai, UAE
Language: English
Novembre 11, 2021
La Société Marocaine de la chirurgie réfractive
Location: Rabat, Morocco
Language: French
Novembre 4, 2021
Sorocaba Eye Bank
Location: Brasile
Language: English
Ottobre 28, 2021
Emirates Society Of Ophthalmology
Location: Dubai, UAE
Language: English
Ottobre 23, 2021
LV Prasad Eye Institute
Location: Hyderabad, India
Language: English
Ottobre 23, 2021
65th Brazilian Congress of Ophthalmology
Location: Natal, Brazil
Language: English
